Foley Catheter for Labor Induction in Women With Term and Near Term Membrane Rupture

April 12, 2017 updated by: Alan Tita, University of Alabama at Birmingham

A Randomized Controlled Trial of Foley Catheter for Labor Induction in Women With Term and Near Term Prelabor Rupture of Membranes (PROM)

In women undergoing labor induction for membrane rupture at or near term, we are investigating the addition of a foley catheter placed in the cervix to standard therapy (oxytocin administration) to decrease the time from the start of the induction to delivery.

Study Overview

Detailed Description

To compare the efficacy of a transcervical Foley catheter with concurrent oxytocin administration compared to oxytocin infusion alone for cervical ripening and labor induction in women with premature rupture of membranes (PROM) at > 34 weeks.

Study Type

Interventional

Enrollment (Actual)

169

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35249
        • University of Alabama at Birmingham
    • Delaware
      • Newark, Delaware, United States, 19713
        • Christiana Care Health System
    • South Carolina
      • Greenville, South Carolina, United States, 29605
        • Greenville Hospital System University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 55 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Preterm rupture of membranes (PROM) (Rupture of membranes = pooling/ferning/nitrazine +) Rupture of membranes (ROM) for ≥1 hour prior to starting induction
  2. Cervix ≤ 2 centimeters (cm)
  3. Gestational age ≥ 34 weeks by best obstetric estimate and clinical management decision is delivery
  4. Singleton gestation
  5. Cephalic
  6. Vertex well applied to cervix

Exclusion Criteria:

  1. Regular uterine contractions (contractions more frequent than every 5 minutes)
  2. Two prior transverse uterine incisions/vertical uterine incision/ transmural myomectomy or any obstetric contraindication to labor
  3. Evidence of chorioamnionitis (temperature of 100.4°F with uterine tenderness and maternal or fetal tachycardia or purulent discharge)
  4. Lethal fetal anomalies
  5. Intrauterine fetal demise (IUFD)
  6. Previa
  7. Suspected abruption/significant hemorrhage
  8. Non-reassuring fetal heart rate (FHR) pattern
  9. Non vertex fetal presentation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Transcervical Foley Catheter
Foley catheter placed through cervix for cervical ripening
No Intervention: No Foley

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hours From Placement of Foley or Initiation of Oxytocin to Delivery
Time Frame: Time from induction to delivery
The outcome measure is the mean in hours of the time from induction to delivery (up to 24 hours)
Time from induction to delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Delivery (Vaginal or Cesarean)by 24 Hours
Time Frame: from start of induction to 24 hours post start of induction
The percent of subjects having transcervical foley catheter and percent of subjects not having transcervical foley catheter delivering within 24 hours.
from start of induction to 24 hours post start of induction
Cesarean Rate
Time Frame: at delivery
The percent of subjects enrolled who had a cesarean at any time for any reason for delivery.
at delivery
Induction to Vaginal Delivery Interval
Time Frame: time from induction to vaginal delivery, up to 24 hours
Mean hours from time of induction to vaginal delivery interval.
time from induction to vaginal delivery, up to 24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alan T Tita, MD, University of Alabama at Birmingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2005

Primary Completion (Actual)

May 1, 2008

Study Completion (Actual)

May 1, 2008

Study Registration Dates

First Submitted

February 9, 2006

First Submitted That Met QC Criteria

February 9, 2006

First Posted (Estimate)

February 10, 2006

Study Record Updates

Last Update Posted (Actual)

May 23, 2017

Last Update Submitted That Met QC Criteria

April 12, 2017

Last Verified

April 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fetal Membranes, Premature Rupture

Clinical Trials on Transcervical Foley catheter

3
Subscribe